Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TTHI

Transition Therapeutics - Ordinary Shares (TTHI)

Transition Therapeutics - Ordinary Shares
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TTHI
DateTimeSourceHeadlineSymbolCompany
12/10/201604:51Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
14/09/201607:16Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
14/09/201607:14Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
10/09/201604:04Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
31/08/201622:56Edgar (US Regulatory)(25-NSE)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
31/08/201620:31Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
31/08/201615:00Business WireOPKO Health Completes Acquisition of Transition TherapeuticsNASDAQ:TTHITransition Therapeutics - Ordinary Shares
26/08/201622:52Business WireTransition Therapeutics Shareholders Approve Acquisition by OPKO HealthNASDAQ:TTHITransition Therapeutics - Ordinary Shares
26/08/201620:02Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
26/08/201608:46PR Newswire (US)Transition Therapeutics Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Ar...NASDAQ:TTHITransition Therapeutics - Ordinary Shares
26/08/201608:46PR Newswire (Canada)Transition Therapeutics Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Ar...NASDAQ:TTHITransition Therapeutics - Ordinary Shares
05/08/201606:07Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
14/07/201606:55Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
07/07/201607:31Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
30/06/201622:15Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
30/06/201616:00Business WireOPKO Health to Acquire Transition TherapeuticsNASDAQ:TTHITransition Therapeutics - Ordinary Shares
03/06/201623:03Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
03/06/201620:01PR Newswire (Canada)Transition Therapeutics Receives Notification From NASDAQNASDAQ:TTHITransition Therapeutics - Ordinary Shares
03/06/201620:01PR Newswire (US)Transition Therapeutics Receives Notification From NASDAQNASDAQ:TTHITransition Therapeutics - Ordinary Shares
12/05/201606:37Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
12/05/201606:01PR Newswire (Canada)Transition Therapeutics Announces Third Quarter Fiscal 2016 Financial ResultsNASDAQ:TTHITransition Therapeutics - Ordinary Shares
12/05/201606:01PR Newswire (US)Transition Therapeutics Announces Third Quarter Fiscal 2016 Financial ResultsNASDAQ:TTHITransition Therapeutics - Ordinary Shares
10/05/201607:45Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
10/05/201606:01PR Newswire (Canada)Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2016 Financial Results on Wednesday, May 11th, at 4:3...NASDAQ:TTHITransition Therapeutics - Ordinary Shares
10/05/201606:01PR Newswire (US)Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2016 Financial Results on Wednesday, May 11th, at 4:3...NASDAQ:TTHITransition Therapeutics - Ordinary Shares
26/04/201623:30Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
26/04/201606:01PR Newswire (Canada)Transition Therapeutics Announces Dosing of First Patient in Phase 2 Study of Drug Candidate TT701NASDAQ:TTHITransition Therapeutics - Ordinary Shares
26/04/201606:01PR Newswire (US)Transition Therapeutics Announces Dosing of First Patient in Phase 2 Study of Drug Candidate TT701NASDAQ:TTHITransition Therapeutics - Ordinary Shares
18/04/201623:05Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
18/04/201620:01PR Newswire (US)Transition Therapeutics Provides Update on Type 2 Diabetes Drug Candidate TT401NASDAQ:TTHITransition Therapeutics - Ordinary Shares
 Showing the most relevant articles for your search:NASDAQ:TTHI